Disinhibition of T Cell Activation Via CD5 Knockout Is a Universal Strategy to Enhance Adoptive T Cell Immunotherapies

被引：0

作者：

Patel, Ruchi P. ^{[1
]}

Ghilardi, Guido ^{[1
]}

Zhang, Yunlin ^{[2
]}

Guruprasad, Puneeth ^{[3
]}

Angelos, Mathew G. ^{[1
]}

Pajarillo, Raymone ^{[2
]}

Gabunia, Khatuna ^{[2
]}

Xu, Chong ^{[2
]}

Blanchard, Tatiana ^{[2
]}

Scholler, John ^{[2
]}

Porazzi, Patrizia ^{[2
]}

Linette, Gerald ^{[2
]}

Carreno, Beatriz M. ^{[4
,5
]}

Ruella, Marco ^{[1
]}

机构：

[1] Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA USA

[2] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA USA

[3] Univ Penn, Perelman Sch Med, Ctr Cellular Immunotherapies, N Wales, PA USA

[4] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA USA

[5] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-186611

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[1] Functions of CD5 in T cell activation and development
Zuckerman, LA
Ferris, W
Dennehy, K
Beyers, A
Killeen, N
FASEB JOURNAL, 1998, 12 (04): : A304 - A304
[2] CD5 deletion enhances the antitumor activity of adoptive T cell therapies
Patel, Ruchi P.
Ghilardi, Guido
Zhang, Yunlin
Chiang, Yi-Hao
Xie, Wei
Guruprasad, Puneeth
Kim, Ki Hyun
Chun, Inkook
Angelos, Mathew G.
Pajarillo, Raymone
Hong, Seok Jae
Lee, Yong Gu
Shestova, Olga
Shaw, Carolyn
Cohen, Ivan
Gupta, Aasha
Vu, Trang
Qian, Dean
Yang, Steven
Nimmagadda, Aditya
Snook, Adam E.
Siciliano, Nicholas
Rotolo, Antonia
Inamdar, Arati
Harris, Jaryse
Ugwuanyi, Ositadimma
Wang, Michael
Carturan, Alberto
Paruzzo, Luca
Chen, Linhui
Ballard, Hatcher J.
Blanchard, Tatiana
Xu, Chong
Abdel-Mohsen, Mohamed
Gabunia, Khatuna
Wysocka, Maria
Linette, Gerald P.
Carreno, Beatriz
Barrett, David M.
Teachey, David T.
Posey, Avery D.
Powell, Daniel J.
Sauter, C. Tor
Pileri, Stefano
Pillai, Vinodh
Scholler, John
Rook, Alain H.
Schuster, Stephen J.
Barta, Stefan K.
Porazzi, Patrizia
SCIENCE IMMUNOLOGY, 2024, 9 (97)
[3] Downregulation of CD5 and dysregulated CD8+ T-cell activation
Wada, Taizo
PEDIATRICS INTERNATIONAL, 2018, 60 (09) : 776 - 780
[4] Regulation of T cell CD5 Levels by BTLA
Adegoke, Adeolu
Sedy, John R.
Ware, Carl F.
Baldwin, Troy A.
Anderson, Colin C.
JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
[5] CD5 Expression in Mature T Cell Lymphoma
Cao, Miao
Tavakkoli, Montreh
Chong, Elise A.
Carter, Jordan S.
Ruella, Marco
Landsburg, Daniel J.
Nasta, Sunita D.
Svoboda, Jakub
Schuster, Stephen J.
Barta, Stefan K.
BLOOD, 2023, 142
[6] Modification of the T cell genome using TALENs for adoptive cell immunotherapies
Gouble, Agnes
Grosse, Stephanie
Raban, Elsa
Smith, Julianne
Scharenberg, Andrew
HUMAN GENE THERAPY, 2012, 23 (10) : A66 - A66
[7] CD5 regulates the heterogenous depot of NFκB available for T cell activation
Matson, Courtney Alexandra
Choi, Seeyoung
Livak, Ferenc
Love, Paul E.
Singh, Nevil J.
JOURNAL OF IMMUNOLOGY, 2021, 206
[8] CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity
Alotaibi, Faizah
Rytelewski, Mateusz
Figueredo, Rene
Zareardalan, Ronak
Zhang, Meng
Ferguson, Peter J.
Vareki, Saman Maleki
Najajreh, Yousef
El-Hajjar, Mikal
Zheng, Xiufen
Min, Wei-ping
Koropatnick, James
EUROPEAN JOURNAL OF IMMUNOLOGY, 2020, 50 (05) : 695 - 704
[9] CD5 CAR for the Treatment of T-Cell Malignancies
Mamonkin, Maksim
Brenner, Malcolm K.
MOLECULAR THERAPY, 2015, 23 : S162 - S163
[10] A universal killer T cell for adoptive cell therapy of cancer
Mensali, Nadia
Dillard, Pierre
Myklebust, June H.
Skorstad, Gjertrud
Myhre, Marit Renee
Fane, Anne
Inderberg, Else Marit
Walchli, Sebastien
Gaudernack, Gustav
Kvalheim, Gunnar
Hebeisen, Michael
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5

← 1 2 3 4 5 →